News

Oscar Health (OSCR) recently reported record first half 2026 results and raised its full year guidance, a combination that appears to have supported renewed investor attention on the stock this month. At a share price of US$30.47, Oscar Health has seen some short term volatility, with a 7 day share price return down 4.9%. However, the 90 day share price return of 37.07% and 3 year total shareholder return of 363.07% suggest momentum has been strong over a longer stretch as investors react to...

Earlier in 2026, Oscar Health reported record first-half financial results and lifted its full-year guidance, prompting analysts to raise their earnings estimates and highlight a low PEG ratio of 0.6 as evidence of relatively modest valuation expectations. This combination of upgraded guidance and analyst estimate revisions underscores how improving profitability expectations are reshaping perceptions of Oscar Health’s earnings power and growth profile. We’ll now examine how Oscar Health’s...

Dow Jones futures: Crude oil continues to climb while bitcoin jumped again amid a weak dollar. Walmart earnings are in focus.

Oscar Health (OSCR) is back in focus after reporting second quarter 2026 results that swung from a loss to net income of $361.81 million and raising full year earnings guidance. See our latest analysis for Oscar Health. Oscar Health shares have been volatile around the earnings release, with an 11.9% drop reported after the outlook update. The stock still shows a 118.84% year to date share price return and a 109.46% 1 year total shareholder return, suggesting momentum remains strong despite...

Oscar Health’s second quarter saw results well above Wall Street’s expectations, yet the market response was notably negative. Management credited disciplined pricing, technology-driven cost efficiencies, and strong execution in the individual health insurance market for driving year-over-year revenue and margin improvement. CEO Mark Bertolini highlighted that “disciplined pricing, differentiated consumer products and a scalable technology platform” fueled growth, with membership up 46% and admi

Oscar Health, Inc. (NYSE:OSCR) shares closed 11.9% lower at $26.54 on August 6, even after the insurer reported its most profitable first half and raised its full-year outlook. Second-quarter revenue rose 70% year over year to $4.88 billion, while the company swung to net income of $361.8 million from a $228.4 million loss. The stock […]

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Oscar Health (NYSE:OSCR) and its peers.

Oscar Health (NYSE:OSCR) reported record profitability for the first half of 2026 and raised its full-year operating outlook, citing membership growth, disciplined pricing, favorable utilization trends and lower administrative expense ratios. Chief Executive Officer Mark Bertolini said the company

Revenue surged 70% as membership grew 46% and operating margins hit record lows.

Oscar Health Inc (OSCR) delivers a stellar Q2 with revenue up 70% and net income of $362 million, prompting a $250 million increase to full-year earnings guidance.

Moby summary of Oscar Health, Inc.'s Q2 2026 earnings call

Oscar Health reported second-quarter 2026 results showing a shift from a prior-year loss to net income of US$361.81 million and lifted its full-year 2026 guidance to total revenue of US$18.70–US$19.00 billion and earnings from operations of US$500–US$700 million. This combination of a profit turnaround and a sizeable upgrade to operating earnings expectations suggests Oscar’s underlying operations are running more efficiently than previously anticipated. We’ll now examine how Oscar’s...

Although the revenue and EPS for Oscar Health (OSCR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Oscar Health (OSCR) delivered earnings and revenue surprises of +155.81% and -0.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Investors pay particular attention to a health insurer’s second-quarter report, which reflects more medical claims data among members.

Octave Specialty heads into Q2 results with revenues projected to jump 47.4%. The bottom line is likely to improve y/y, though the model does not signal a beat.

PRU's Q2 results are expected to reflect strength in Retirement, Individual Life and PGIM despite pressure in Group Insurance.

AIZ's Q2 results are expected to benefit from growth in Global Housing and Global Lifestyle, supported by higher premiums and investment income.

Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Goosehead (GSHD) delivered earnings and revenue surprises of +23.08% and +9.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Solid retention, renewals, prudent pricing, exposure growth and improved digitization are expected to help CINF, RGA, OSCR, WTW and AFL outperform Q2 estimates.

Oscar Health (OSCR) has been back on investors’ radar after a sharp stock rally following its business update at the Goldman Sachs Healthcare Conference, where management reaffirmed full-year 2026 guidance and highlighted favorable utilization trends. See our latest analysis for Oscar Health. The stock’s rally around the Goldman Sachs Healthcare Conference and upbeat commentary on utilization trends come on top of very strong momentum, with a 90 day share price return of 118.52% and a 1 year...

Despite ACA market challenges and exits by Cigna and Aetna, Oscar sees competitor withdrawals as a potential opportunity for growth in 2027.

Oscar Health’s first quarter results prompted a positive market reaction as management delivered substantial improvements in profitability, even as revenue came in below consensus. CEO Mark Bertolini attributed the performance to disciplined expense management, robust membership growth, and the growing impact of artificial intelligence (AI) across operations. Notably, Oscar’s medical loss ratio improved sharply, and management highlighted the effectiveness of new technology-driven transparency t

Klaviyo delivers cloud-based marketing automation tools to businesses worldwide, powering personalized digital communications at scale.

Oscar Health, Inc. has already reported its first-quarter 2026 results, posting revenue of US$4.65 billion and net income of US$679.00 million, with basic earnings per share from continuing operations of US$2.28. The quarter marked record profitability for the company, with management highlighting technology-led membership growth and reaffirming full-year 2026 guidance despite revenue finishing below consensus expectations. Now we’ll examine how Oscar’s record quarterly earnings and...

Moby summary of Oscar Health, Inc.'s Q1 2026 earnings call

Need a quote from a Motley Fool analyst? Mark Bertolini, Oscar Health's Chief Executive Officer; and Scott Blackley, Oscar Health's Chief Financial Officer, will host this morning's call. This call can also be accessed through our Investor Relations website at ir.hioscar.com.

Oscar Health (NYSE:OSCR) surged nearly 11% in premarket trading on Wednesday after the company reported first-quarter earnings far above Wall Street expectations, driven by strong profitability gains and improving operating margins. The health insurance provider posted adjusted earnings per share of $2.

Oscar Health (OSCR) delivered earnings and revenue surprises of +71.07% and -5.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?